The landscape of dementia prognosis has progressed considerably with the appearance of advanced biomarkers, like amyloid PET scans, tau imaging, and blood-centered tests that may detect Alzheimer's pathology several years in advance of indications arise. While these technological advances signify impressive progress in knowledge neurodegenerative d